Immuneering Corporation IMRX
4.27
(0.07)
(1.61%)
as of 25 Sep
- Market cap
- $280.8M
- P/E
- 0.0×
Follow IMRX
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
23.84 | 17.16 | 31.50 | 18.47 | |
Current Ratio |
24.00 | 17.50 | 32.45 | 19.47 | |
Net Debt/EBITDA |
14.96 | 12.58 | 10.07 | 7.73 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.80 | 0.85 | 1.37 | 0.96 | |
Capex/Depreciation |
(0.04) | (7.33) | 0.36 | 0.07 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.03 | 0.03 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.30) | (0.22) | (0.29) | (0.26) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.30) | (0.23) | (0.29) | (0.26) | |
Cash per Share |
5.74 | 3.93 | 2.42 | 2.32 | |
Shareholders Equity per Share |
5.75 | 4.96 | 3.19 | 2.95 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.75 | 4.96 | 3.19 | 2.95 | |
Free Cash Flow |
(11.98) | (9.96) | (18.51) | (16.53) | |
Working Capital |
219.56 | 166.17 | 156.43 | 149.87 | |
Capital Expenditures |
(0.01) | (0.12) | (0.08) | (0.03) | |
Net Current Asset Value |
216.02 | 162.75 | 153.12 | 146.67 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
1.77 | 1.75 | 1.38 | 2.89 | |
Average Assets |
154.81 | 142.35 | 132.75 | 121.06 | |
Average Common Equity |
142.85 | 129.94 | 124.18 | 109.84 |
Columns are period end dates